Literature DB >> 26354610

Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.

Nathella Pavan Kumar1, Vaithilingam V Banurekha2, Dina Nair2, Paul Kumaran2, Chandra Kumar Dolla2, Subash Babu3.   

Abstract

IL-20 subfamily of cytokines play an important role in both host defense mechanisms and glucose metabolism. Since, the interaction between tuberculosis (TB) and diabetes (DM) involves both of the above processes, we examined the association of IL-20 subfamily of cytokines in TB-DM co-morbidity. We examined circulating plasma cytokine levels in individuals with active TB with (PTB-DM) or without (PTB) diabetes and also those with latent TB with (LTB-DM) or without (LTB) diabetes. PTB-DM is characterized by diminished circulating levels of IL-19, IL-20, IL-22 and IL-24 but increased levels of IL-10. Similarly, LTB-DM was also characterized by diminished circulating levels of IL-10, IL-19, IL-20 and IL-24 but increased levels of IL-22. Moreover, there was a significant negative correlation of IL-10, IL-19, IL-20, IL-22 and IL-24 levels with hemoglobin A1C (HbA1c) levels in both PTB and/or LTB individuals. Finally, PTB is characterized by diminished levels of IL-19, IL-20, IL-22 and IL-24 in comparison to LTB individuals. Our data reveal that coincident diabetes in either PTB or LTB is characterized by decreased production of the IL-20 subfamily of cytokines and suggest that these cytokines might play an important role in pathogenesis or protection. Published by Elsevier Ltd.

Entities:  

Keywords:  Bacterial; Cytokines; Diabetes; IL-10; IL-20 subfamily; Tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26354610      PMCID: PMC4666794          DOI: 10.1016/j.tube.2015.06.004

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  32 in total

1.  IL-22 defines a novel immune pathway of antifungal resistance.

Authors:  A De Luca; T Zelante; C D'Angelo; S Zagarella; F Fallarino; A Spreca; R G Iannitti; P Bonifazi; J-C Renauld; F Bistoni; P Puccetti; L Romani
Journal:  Mucosal Immunol       Date:  2010-05-05       Impact factor: 7.313

Review 2.  IL-10 family of cytokines.

Authors:  Robert Sabat
Journal:  Cytokine Growth Factor Rev       Date:  2010-10       Impact factor: 7.638

Review 3.  IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.

Authors:  Rui-Xue Leng; Hai-Feng Pan; Jin-Hui Tao; Dong-Qing Ye
Journal:  Expert Opin Ther Targets       Date:  2010-11-12       Impact factor: 6.902

Review 4.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

Review 5.  Type 2 diabetes as an inflammatory disease.

Authors:  Marc Y Donath; Steven E Shoelson
Journal:  Nat Rev Immunol       Date:  2011-01-14       Impact factor: 53.106

Review 6.  Regulation and functions of the IL-10 family of cytokines in inflammation and disease.

Authors:  Wenjun Ouyang; Sascha Rutz; Natasha K Crellin; Patricia A Valdez; Sarah G Hymowitz
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 7.  The role of IL-10 in immune regulation during M. tuberculosis infection.

Authors:  P S Redford; P J Murray; A O'Garra
Journal:  Mucosal Immunol       Date:  2011-03-30       Impact factor: 7.313

Review 8.  State of the union between metabolism and the immune system in type 2 diabetes.

Authors:  B S Nikolajczyk; M Jagannathan-Bogdan; H Shin; R Gyurko
Journal:  Genes Immun       Date:  2011-03-10       Impact factor: 2.676

9.  IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation.

Authors:  Murielle Corvaisier; Yves Delneste; Henry Jeanvoine; Laurence Preisser; Simon Blanchard; Erwan Garo; Emmanuel Hoppe; Benjamin Barré; Maurice Audran; Béatrice Bouvard; Jean-Paul Saint-André; Pascale Jeannin
Journal:  PLoS Biol       Date:  2012-09-25       Impact factor: 8.029

10.  Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells.

Authors:  Blanca I Restrepo; Susan P Fisher-Hoch; Paula A Pino; Adrian Salinas; Mohammad H Rahbar; Francisco Mora; Nicolas Cortes-Penfield; Joseph B McCormick
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 20.999

View more
  8 in total

1.  Modulation of Th1/Tc1 and Th17/Tc17 responses in pulmonary tuberculosis by IL-20 subfamily of cytokines.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Vaithilingam V Banurekha; Dina Nair; Subash Babu
Journal:  Cytokine       Date:  2018-04-21       Impact factor: 3.861

2.  Diminished circulating plasma and elevated lymph node culture supernatant levels of IL-10 family cytokines in tuberculous lymphadenitis.

Authors:  Gokul Raj Kathamuthu; Nathella Pavan Kumar; Kadar Moideen; Dhanaraj Baskaran; Syed Hissar; Basavegowdanadoddi M Shrinivasa; Rathinam Sridhar; Subash Babu
Journal:  Cytokine       Date:  2018-06-02       Impact factor: 3.861

Review 3.  Influence of diabetes mellitus on immunity to human tuberculosis.

Authors:  Pavan Kumar Nathella; Subash Babu
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

Review 4.  Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases.

Authors:  Mitchell E Menezes; Praveen Bhoopathi; Anjan K Pradhan; Luni Emdad; Swadesh K Das; Chunqing Guo; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

Review 5.  Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms.

Authors:  Katharina Ronacher; Reinout van Crevel; Julia A Critchley; Andrew A Bremer; Larry S Schlesinger; Anil Kapur; Randall Basaraba; Hardy Kornfeld; Blanca I Restrepo
Journal:  Chest       Date:  2017-04-20       Impact factor: 9.410

Review 6.  IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?

Authors:  Katharina Ronacher; Roma Sinha; Michelle Cestari
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

7.  IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis.

Authors:  Deepak Tripathi; Rajesh Kumar Radhakrishnan; Ramya Sivangala Thandi; Padmaja Paidipally; Kamakshi Prudhula Devalraju; Venkata Sanjeev Kumar Neela; Madeline Kay McAllister; Buka Samten; Vijaya Lakshmi Valluri; Ramakrishna Vankayalapati
Journal:  PLoS Pathog       Date:  2019-12-06       Impact factor: 6.823

Review 8.  Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis.

Authors:  B R Imperiale; A García; A Minotti; P González Montaner; L Moracho; N S Morcillo; D J Palmero; M Del Carmen Sasiain; S de la Barrera
Journal:  Clin Exp Immunol       Date:  2020-11-18       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.